KC-5783

Jurkat-NFAT-Luc2-CD7-KO-CD16a-V158 Cell Line

×
请在浏览器中启用JavaScript来完成此表单。
63934
Home » Jurkat-NFAT-Luc2-CD7-KO-CD16a-V158 Cell Line

Background of Jurkat-NFAT-Luc2-CD7-KO-CD16a-V158 Cell Line

CD7 (CD7 Molecule) is a Protein Coding gene. This gene encodes a transmembrane protein which is a member of the immunoglobulin superfamily. This protein is found on thymocytes and mature T cells and also on natural killer (NK) cells. It plays an essential role in T-cell interactions and also in T-cell/B-cell interaction during early lymphoid development. The encoded protein functions as a costimulatory receptor in T-cell activation upon binding to its ligand SECTM1 (secreted and transmembrane 1), mediating the production of cytokines such as IL-2. CD7 is useful as a marker for T-cell acute lymphocytic leukemias. Alternative splice variants have been described but their full-length sequences have not been determined. CD16, also named FC gamma RIII, is a low or intermediate affinity FC receptor, and has been identified as two receptors including FcγRIIIa (CD16a) and FcγRIIIb (CD16b). It is involved in phagocytosis, secretion of enzymes and inflammatory mediators, antibody-dependent cytotoxicity and clearance of immune complexes. NFAT proteins, which are expressed in most immune-system cells, play a pivotal role in the transcription of cytokine genes and other genes critical for the immune response. Nuclear factor of activated T cells (NFAT), which is the pharmacological target of immunosuppressants cyclosporine and tacrolimus, has been shown to play an important role not only in T cells (immune system), from which their ame is derived, but also in many biological events. The activity of NFAT proteins is tightly regulated by the calcium/calmodulin-dependent phosphatase calcineurin, a primary target for inhibition by cyclosporin A and FK506. Calcineurin controls the translocation of NFAT proteins from the cytoplasm to the nucleus of activated cells by interacting with an N-terminal regulatory domain conserved in the NFAT family. The DNA-binding domains of NFAT proteins resemble those of Rel-family proteins, and Rel and NFAT proteins show some overlap in their ability to bind to certain regulatory elements in cytokine genes. NFAT is also notable for its ability to bind cooperatively with transcription factors of the AP-1 (Fos/Jun) family to composite NFAT: AP-1 sites, found in the regulatory regions of many genes that are inducibly transcribed by immune-system cells.

Specifications

Catalog NumberKC-5783
Cell Line NameJurkat-NFAT-Luc2-CD7-KO-CD16a-V158 Cell Line
Clone Number1A4
Host Cell LineJurkat-NFAT-Luc2-CD16a-V158
DescriptionStable Jurkat-NFAT-Luc2-CD16a-V158 clone with CD7 gene knockout, No.1A4
QuantityOne vial of frozen cells (≥2-106/vial)
StabilityStable in culture over a minimum of 10 passages
ApplicationDrug screening and biological assays
Freezing Medium70% RPMI1640+20% FBS+10% DMSO
Propagation Medium90% RPMI1640+10% FBS
Selection MarkerNA
Morphologylymphoblast
SubcultureSplit saturated culture 1:5-1:8 every 2-3 days; seed out at about 1-3 × 105 cells/mL
Incubation37 °C with 5% CO2
StorageLiquid nitrogen immediately upon receiving
Doubling TimeApproximately 26 hours
Mycoplasma StatusNegative

Cell Line Generation

Jurkat-NFAT-Luc2-CD7-KO-CD16a-V158 cell line was generated using the CRISPR method.

Characterization

Figure 1: Characterization of Jurkat-NFAT-Luc2-CD7-KO-CD16a-V158 cell line stable clone using PCR sequencing.

Figure 2: Characterization of Jurkat-NFAT-Luc2-CD7-KO-CD16a-V158 cell line stable clone using RT-PCR sequencing.

Figure 3: Characterization of Jurkat-NFAT-Luc2-CD7-KO-CD16a-V158 cell line stable clone using FACS.

Cell Resuscitation

  1. Prewarm culture medium (90% RPMI1640+10% FBS) in a 37°C water bath.
  2. Thaw the frozen vial in a 37°C water bath for 1-2 minutes.
  3. Transfer the vial into biosafety cabinet, and wipe the surface with 70% ethanol.
  4. Unscrew the top of the vial and transfer the cell suspension gently into a sterile centrifuge tube containing 9.0mL complete culture medium.
  5. Spin at ~ 125 × g for 5-7 minutes at room temperature, and discard the supernatant without disturbing the pellet.
  6. Resuspend cell pellet with the appropriate volume of complete medium and transfer the cell suspension into a T25 culture flask.
  7. Incubate the flask at 37°C, 5% CO2 incubator.
  8. Split saturated culture 1:5-1:8 every 2-3 days; seed out at about 1-3 ×105 cells/mL.

Cell Freezing

  1. Prepare the freezing medium (70% RPMI1640 + 20% FBS + 10% DMSO) fresh immediately before use.
  2. Keep the freezing medium on ice and label cryovials.
  3. Transfer cells to a sterile, conical centrifuge tube, and count the cells.
  4. Centrifuge the cells at 250×g for 5 minutes at room temperature and carefully aspirate off the medium.
  5. Resuspend the cells at a density of at least 3×106 cells/mL in chilled freezing medium.
  6. Aliquot 1 mL of the cell suspension into each cryovial.
  7. Freeze cells in the CoolCell freezing container overnight in a -80°C freezer.
  8. Transfer vials to liquid nitrogen for long-term storage.

References

  1. Schanberg LE, Fleenor DE, Kurtzberg J, Haynes BF, Kaufman RE. Isolation and characterization of the genomic human CD7 gene: structural similarity with the murine Thy-1 gene. Proc Natl Acad Sci U S A. 1991 Jan 15;88(2):603-7. doi: 10.1073/pnas.88.2.603. PMID: 1703304; PMCID: PMC50856.
  2. Lyman SD, Escobar S, Rousseau AM, Armstrong A, Fanslow WC. Identification of CD7 as a cognate of the human K12 (SECTM1) protein. J Biol Chem. 2000 Feb 4;275(5):3431-7. doi: 10.1074/jbc.275.5.3431. PMID: 10652336.
  3. Tada, Minoru, Akiko Ishii-Watabe, Takuo Suzuki, and Nana Kawasaki. 2014. ¡ùDevelopment of a Cell-Based Assay Measuring the Activation of FcÎÛRIIa for the Characterization of Therapeutic Monoclonal Antibodies.¡ì Edited by Paul Zhou. PLoS ONE 9 (4): e95787ÿ89. doi:10.1371/journal.pone.0095787.
  4. Koene, H R, M Kleijer, J Algra, D Roos, A E von dem Borne, and M de Haas. 1997. ¡ùFc gammaRIIIa-158V/F Polymorphism Influences the Binding of IgG by Natural Killer Cell Fc gammaRIIIa, Independently of the Fc gammaRIIIa-48L/R/H Phenotype..¡ì Blood 90 (3): 1109ÿ14.
  5. Rao A, Luo C, Hogan PG. Transcription factors of the NFAT family: regulation and function. Annu Rev Immunol. 1997;15:707-47.
  6. Kitamura N, Kaminuma O. Isoform-Selective NFAT Inhibitor: Potential Usefulness and Development. Int J Mol Sci. 2021 Mar 8;22(5):2725.
  7. Sana I, Mantione ME, Angelillo P, Muzio M. Role of NFAT in Chronic Lymphocytic Leukemia and Other B-Cell Malignancies. Front Oncol. 2021 Apr 1;11:651057.

Use License Agreement

Research Use Only.
Not for use in diagnostic procedures or therapeutic applications.
Redistribution of the cell line or its derivatives is prohibited without prior written permission from Kyinno Biotechnology.
请在浏览器中启用JavaScript来完成此表单。